scispace - formally typeset
Search or ask a question
Author

Juan R. Muñoz-Castañeda

Bio: Juan R. Muñoz-Castañeda is an academic researcher from University of Córdoba (Spain). The author has contributed to research in topics: Oxidative stress & Lipid peroxidation. The author has an hindex of 27, co-authored 65 publications receiving 2594 citations. Previous affiliations of Juan R. Muñoz-Castañeda include Carlos III Health Institute & Sofia University.


Papers
More filters
Journal ArticleDOI
TL;DR: A number of authors have suggested that apoptosis and necrosis are no separate processes but the opposing ends in only one cell mechanism designated necrapoptosis.
Abstract: Cell death is a process accompanying many physiological and pathological situations in organisms. The first cell death pattern that was identified was cell necrosis, described by Virchow in 1871. It was subsequently seen that cell death was an integral part of normal cell and tissue differentiation mechanisms in superior organisms. In this respect early embryological studies revealed that cell death processes were required to model organisms in their final configuration. Morphogenesis systematically entails the removal and generation of new cell and tissue structures. A similar phenomenon is encountered during metamorphosis in invertebrates and inferior vertebrates, where massive tissue involution and cell clearance are coordinately developed physiological processes. This cell death process, designated apoptosis, was characterized by Kerr in 1965. Cell apoptosis and necrosis can be differentiated by a number of both morphological and biochemical parameters. Apoptosis is a controlled removal of the involved cell with no relevant changes in cell metabolism. This process is characterized by the sequential activation of a number of proteases known as caspases, which affect cysteine-aspartate bonds in the substrate. Caspase activation entails DNA fragmentation and cell architecture changes, associated with morphological changes such as nuclear DNA condensation, decreased cell volume, and the generation of apoptotic bodies with no intracellular contents release. Necrosis results from an extreme disruption of cell balance dramatically affecting cell metabolism with a drastic decrease in cell energy contents in the form of adenosine triphosphate (ATP), ion contents changes, increased mitochondrial and cell volume, and intracellular protease activation. This process ultimately leads to a disruption of cell membranes, and release of cell contents, which promotes a secondary inflammatory response. In the liver cell apoptosis usually has a focal distribution, whereas necrosis shows a regional distribution. Despite a clear-cut differentiation between apoptosis and necrosis, both types of cell death usually coexist in the liver, because one stimulus may induce apoptosis or necrosis depending on cell type involved, exposure extent, cell metabolic status, and the integrity of the machinery involved in cell death. In this sense a number of authors have suggested that apoptosis and necrosis are no separate processes but the opposing ends in only one cell mechanism designated necrapoptosis (1). Mitochondriagenerated ATP contents are a key factor in the regulation of apoptosis or necrosis induction during the process of cell death. In this respect a lesion involving a few mitochondria may be solved by autophagia of altered organelles. If more mitochondria are involved, and an adequate amount of proapoptotic factors is released while intracellular ATP levels remain, the cell undergoes apoptosis. If the cell undergoes a severe lesion, the dramatic reduction of ATP contents will not allow for many enerMechanisms of liver cell injury

366 citations

Journal ArticleDOI
TL;DR: In parathyroidectomized rats, an increase in dietary calcium for 10 days increased serum calcium, with an associated increase in FGF23, decrease in calcitriol, and no change in phosphorus, which suggests that hypocalcemia reduces the circulating concentrations of FGF 23.
Abstract: Fibroblast growth factor (FGF) 23 inhibits calcitriol production, which could exacerbate calcium deficiency or hypocalcemia unless calcium itself modulates FGF23 in this setting. In Wistar rats with normal renal function fed a diet low in both calcium and vitamin D, the resulting hypocalcemia was associated with low FGF23 despite high parathyroid hormone (PTH) and high calcitriol levels. FGF23 correlated positively with calcium and negatively with PTH. Addition of high dietary phosphorus to this diet increased FGF23 except in rats with hypocalcemia despite high PTH levels. In parathyroidectomized rats, an increase in dietary calcium for 10 days increased serum calcium, with an associated increase in FGF23, decrease in calcitriol, and no change in phosphorus. Also in parathyroidectomized rats, FGF23 increased significantly 6 hours after administration of calcium gluconate. Taken together, these results suggest that hypocalcemia reduces the circulating concentrations of FGF23. This decrease in FGF23 could be a response to avoid a subsequent reduction in calcitriol, which could exacerbate hypocalcemia.

193 citations

Journal ArticleDOI
TL;DR: In hyperparathyroidism secondary to renal failure, the parathyroid cells resist the inhibitory effects of FGF23, perhaps as a result of the low expression of F GF23 receptor 1 and Klotho in this condition.
Abstract: Fibroblast growth factor 23 (FGF23) modulates mineral metabolism by promoting phosphaturia and decreasing the production of 1,25-dihydroxyvitamin D(3). FGF23 decreases parathyroid hormone (PTH) mRNA and secretion, but despite a marked elevation in FGF23 in uremia, PTH production increases. Here, we investigated the effect of FGF23 on parathyroid function in normal and uremic hyperplastic parathyroid glands in rats. In normal parathyroid glands, FGF23 decreased PTH production, increased expression of both the parathyroid calcium-sensing receptor and the vitamin D receptor, and reduced cell proliferation. Furthermore, FGF23 induced phosphorylation of extracellular signal-regulated kinase 1/2, which mediates the action of FGF23. In contrast, in hyperplastic parathyroid glands, FGF23 did not reduce PTH production, did not affect expression of the calcium-sensing receptor or vitamin D receptor, and did not affect cell proliferation. In addition, FGF23 failed to activate the extracellular signal-regulated kinase 1/2-mitogen-activated protein kinase pathway in hyperplastic parathyroid glands. We observed very low expression of the FGF23 receptor 1 and the co-receptor Klotho in uremic hyperplastic parathyroid glands, which may explain the lack of response to FGF23 in this tissue. In conclusion, in hyperparathyroidism secondary to renal failure, the parathyroid cells resist the inhibitory effects of FGF23, perhaps as a result of the low expression of FGF23 receptor 1 and Klotho in this condition.

161 citations

Journal ArticleDOI
25 Feb 2014-PLOS ONE
TL;DR: In conclusion, magnesium transport through the cell membrane is important to inhibit VSMC calcification in vitro and inhibition of Wnt/β-catenin by magnesium is one potential intracellular mechanism by which this anti-calcifying effect is achieved.
Abstract: Magnesium reduces vascular smooth muscle cell (VSMC) calcification in vitro but the mechanism has not been revealed so far. This work used only slightly increased magnesium levels and aimed at determining: a) whether inhibition of magnesium transport into the cell influences VSMC calcification, b) whether Wnt/β-catenin signaling, a key mediator of osteogenic differentiation, is modified by magnesium and c) whether magnesium can influence already established vascular calcification. Human VSMC incubated with high phosphate (3.3 mM) and moderately elevated magnesium (1.4 mM) significantly reduced VSMC calcification and expression of the osteogenic transcription factors Cbfa-1 and osterix, and up-regulated expression of the natural calcification inhibitors matrix Gla protein (MGP) and osteoprotegerin (OPG). The protective effects of magnesium on calcification and expression of osteogenic markers were no longer observed in VSMC cultured with an inhibitor of cellular magnesium transport (2-aminoethoxy-diphenylborate [2-APB]). High phosphate induced activation of Wnt/β-catenin pathway as demonstrated by the translocation of β-catenin into the nucleus, increased expression of the frizzled-3 gene, and downregulation of Dkk-1 gene, a specific antagonist of the Wnt/β-catenin signaling pathway. The addition of magnesium however inhibited phosphate-induced activation of Wnt/β-catenin signaling pathway. Furthermore, TRPM7 silencing using siRNA resulted in activation of Wnt/β-catenin signaling pathway. Additional experiments were performed to test the ability of magnesium to halt the progression of already established VSMC calcification in vitro. The delayed addition of magnesium decreased calcium content, down-regulated Cbfa-1 and osterix and up-regulated MGP and OPG, when compared with a control group. This effect was not observed when 2-APB was added. In conclusion, magnesium transport through the cell membrane is important to inhibit VSMC calcification in vitro. Inhibition of Wnt/β-catenin by magnesium is one potential intracellular mechanism by which this anti-calcifying effect is achieved.

131 citations

Journal ArticleDOI
16 Jun 2014-PLOS ONE
TL;DR: The pharmacological induction of hypoxia in colon cancer cells causes the formation of PGCCs, the expansion of a cell subpopulation with CSC characteristics and chemoresistance, and the molecular mechanisms involved suggest novel targets to prevent tumor relapse and treatment failure in Colon cancer.
Abstract: The induction of polyploidy is considered the reproductive end of cells, but there is evidence that polyploid giant cancer cells (PGCCs) contribute to cell repopulation during tumor relapse. However, the role of these cells in the development, progression and response to therapy in colon cancer remains undefined. Therefore, the main objective of this study was to investigate the generation of PGCCs in colon cancer cells and identify mechanisms of formation. Treatment of HCT-116 and Caco-2 colon cancer cells with the hypoxia mimic CoCl2 induced the formation of cells with larger cell and nuclear size (PGCCs), while the cells with normal morphology were selectively eliminated. Cytometric analysis showed that CoCl2 treatment induced G2 cell cycle arrest and the generation of a polyploid cell subpopulation with increased cellular DNA content. Polyploidy of hypoxia-induced PGCCs was confirmed by FISH analysis. Furthermore, CoCl2 treatment effectively induced the stabilization of HIF-1α, the differential expression of a truncated form of p53 (p47) and decreased levels of cyclin D1, indicating molecular mechanisms associated with cell cycle arrest at G2. Generation of PGCCs also contributed to expansion of a cell subpopulation with cancer stem cells (CSCs) characteristics, as indicated by colonosphere formation assays, and enhanced chemoresistance to 5-fluorouracil and oxaliplatin. In conclusion, the pharmacological induction of hypoxia in colon cancer cells causes the formation of PGCCs, the expansion of a cell subpopulation with CSC characteristics and chemoresistance. The molecular mechanisms involved, including the stabilization of HIF-1 α, the involvement of p53/p47 isoform and cell cycle arrest at G2, suggest novel targets to prevent tumor relapse and treatment failure in colon cancer.

113 citations


Cited by
More filters
Journal ArticleDOI
01 May 1981
TL;DR: This chapter discusses Detecting Influential Observations and Outliers, a method for assessing Collinearity, and its applications in medicine and science.
Abstract: 1. Introduction and Overview. 2. Detecting Influential Observations and Outliers. 3. Detecting and Assessing Collinearity. 4. Applications and Remedies. 5. Research Issues and Directions for Extensions. Bibliography. Author Index. Subject Index.

4,948 citations

Journal ArticleDOI
21 Jul 1979-BMJ
TL;DR: It is suggested that if assessment of overdoses were left to house doctors there would be an increase in admissions to psychiatric units, outpatients, and referrals to social services, but for house doctors to assess overdoses would provide no economy for the psychiatric or social services.
Abstract: admission. This proportion could already be greater in some parts of the country and may increase if referrals of cases of self-poisoning increase faster than the facilities for their assessment and management. The provision of social work and psychiatric expertise in casualty departments may be one means of preventing unnecessary medical admissions without risk to the patients. Dr Blake's and Dr Bramble's figures do not demonstrate, however, that any advantage would attach to medical teams taking over assessment from psychiatrists except that, by implication, assessments would be completed sooner by staff working on the ward full time. What the figures actually suggest is that if assessment of overdoses were left to house doctors there would be an increase in admissions to psychiatric units (by 19°U), outpatients (by 5O°'), and referrals to social services (by 140o). So for house doctors to assess overdoses would provide no economy for the psychiatric or social services. The study does not tell us what the consequences would have been for the six patients who the psychiatrists would have admitted but to whom the house doctors would have offered outpatient appointments. E J SALTER

4,497 citations

Journal ArticleDOI
TL;DR: Clinical and translational implications of these advances have become clear, and have begun to impact significantly on the management and outlook of patients with chronic liver disease.

2,421 citations

Journal ArticleDOI
TL;DR: This report reviews the studies which document the influence of melatonin on the activity and expression of the antioxidative enzymes glutathione peroxidase, superoxide dismutases and catalase both under physiological and under conditions of elevated oxidative stress and analyses the possible mechanisms by which melatonin regulates these enzymes.
Abstract: Antioxidant enzymes form the first line of defense against free radicals in organisms. Their regulation depends mainly on the oxidant status of the cell, given that oxidants are their principal modulators. However, other factors have been reported to increase antioxidant enzyme activity and/or gene expression. During the last decade, the antioxidant melatonin has been shown to possess genomic actions, regulating the expression of several genes. Melatonin also influences both antioxidant enzyme activity and cellular mRNA levels for these enzymes. In the present report, we review the studies which document the influence of melatonin on the activity and expression of the antioxidative enzymes glutathione peroxidase, superoxide dismutases and catalase both under physiological and under conditions of elevated oxidative stress. We also analyze the possible mechanisms by which melatonin regulates these enzymes.

1,824 citations

Journal ArticleDOI
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht1, Melvin E. Andersen, Nariman Ansari2, Sudin Bhattacharya, Johannes G. Bode1, Jennifer Bolleyn3, Christoph Borner4, J Böttger5, Albert Braeuning, Robert A. Budinsky6, Britta Burkhardt7, Neil R. Cameron8, Giovanni Camussi9, Chong Su Cho10, Yun Jaie Choi10, J. Craig Rowlands6, Uta Dahmen11, Georg Damm12, Olaf Dirsch11, María Teresa Donato13, Jian Dong, Steven Dooley14, Dirk Drasdo5, Dirk Drasdo15, Dirk Drasdo16, Rowena Eakins17, Karine Sá Ferreira4, Valentina Fonsato9, Joanna Fraczek3, Rolf Gebhardt5, Andrew Gibson17, Matthias Glanemann12, Christopher E. Goldring17, María José Gómez-Lechón, Geny M. M. Groothuis18, Lena Gustavsson19, Christelle Guyot, David Hallifax20, Seddik Hammad21, Adam S. Hayward8, Dieter Häussinger1, Claus Hellerbrand22, Philip Hewitt23, Stefan Hoehme5, Hermann-Georg Holzhütter12, J. Brian Houston20, Jens Hrach, Kiyomi Ito24, Hartmut Jaeschke25, Verena Keitel1, Jens M. Kelm, B. Kevin Park17, Claus Kordes1, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz4, Daniel J. Maltman, Madlen Matz-Soja5, Patrick D. McMullen, Irmgard Merfort4, Simon Messner, Christoph Meyer14, Jessica Mwinyi, Dean J. Naisbitt17, Andreas K. Nussler7, Peter Olinga18, Francesco Pampaloni2, Jingbo Pi, Linda J. Pluta, Stefan Przyborski8, Anup Ramachandran25, Vera Rogiers3, Cliff Rowe17, Celine Schelcher26, Kathrin Schmich4, Michael Schwarz, Bijay Singh10, Ernst H. K. Stelzer2, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta27, Wolfgang E. Thasler26, Tamara Vanhaecke3, Mathieu Vinken3, Thomas S. Weiss28, Agata Widera, Courtney G. Woods, Jinghai James Xu29, Kathy Yarborough, Jan G. Hengstler 
TL;DR: This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro and how closely hepatoma, stem cell and iPS cell–derived hepatocyte-like-cells resemble real hepatocytes.
Abstract: This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell-derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.

1,085 citations